Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Galectin functions in cancer-associated inflammation and thrombosis
Linus Kruk, Attila Braun, Érika Cosset, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 12

Showing 12 citing articles:

Vincamine ameliorates hepatic fibrosis via inhibiting S100A4‐mediated farnesoid X receptor activation: based on liver microenvironment and enterohepatic circulation dependence
Jun Chen, Jia Guo, Sheng Liu, et al.
British Journal of Pharmacology (2025)
Closed Access
Galectin inhibitors and nanoparticles as a novel therapeutic strategy for glioblastoma multiforme
Willie Elliott
American Journal of Cancer Research (2024) Vol. 14, Iss. 2, pp. 774-795
Open Access | Times Cited: 3
Comprehensive Quality Analysis of Conventional and Novel Biomarkers in Diagnosing and Predicting Prognosis of Coronary Artery Disease, Acute Coronary Syndrome, and Heart Failure, a Comprehensive Literature Review
Muhammad Abubakar, Umema Irfan, Ahmad Abdelkhalek, et al.
Journal of Cardiovascular Translational Research (2024) Vol. 17, Iss. 6, pp. 1258-1285
Closed Access | Times Cited: 3
The expression of Galectin‐9 correlates with mTOR and AMPK in murine colony‐forming erythroid progenitors
Tetsuo Tsukamoto
European Journal Of Haematology (2024)
Closed Access | Times Cited: 2
Matricellular proteins: Potential biomarkers in head and neck cancer
Yunsheng Wang, Xudong Liu, Xingyue Wang, et al.
Journal of Cell Communication and Signaling (2024) Vol. 18, Iss. 2
Open Access | Times Cited: 2
Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities
Ana Bogut, Bojan Stojanović, Marina Jovanović, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15500-15500
Open Access | Times Cited: 6
Ginseng-derived type I rhamnogalacturonan polysaccharide binds to galectin-8 and antagonizes its function
Yi Zheng, Yunlong Si, Xuejiao Xu, et al.
Journal of Ginseng Research (2023) Vol. 48, Iss. 2, pp. 202-210
Open Access | Times Cited: 5
Non-carbohydrate Galectin-1 inhibitors as promising anticancer agents: Design strategies, structure activity relationship and mechanistic insights
Sridhar Goud Nerella
European Journal of Medicinal Chemistry Reports (2024) Vol. 11, pp. 100170-100170
Open Access | Times Cited: 1
Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia?
Justyna Woś, Agata Szymańska, Natalia Lehman, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 30-30
Open Access | Times Cited: 3
RG-I-containing sugar domains from Centella Asiatica bind strongly to galectin-3 to inhibit cell–cell interactions
Xuejiao Xu, Zhen He, Xinlin Luo, et al.
Chemical and Biological Technologies in Agriculture (2024) Vol. 11, Iss. 1
Open Access
Shaping hematopoietic cell ecosystems through galectin-glycan interactions
Mirta Schattner, Bethan Psaila, Gabriel A. Rabinovich
Seminars in Immunology (2024) Vol. 74-75, pp. 101889-101889
Closed Access
Soluble galectin-4 in colorectal cancer is associated with tumor progression, but is not a predictor of the disease outcome
E. Yu. Yakunina, О. В. Ковалева, Р. А. Зуков, et al.
Almanac of Clinical Medicine (2024)
Open Access
Page 1

Scroll to top